Sukyung Woo

2.7k total citations · 1 hit paper
63 papers, 2.2k citations indexed

About

Sukyung Woo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Sukyung Woo has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Biomedical Engineering. Recurrent topics in Sukyung Woo's work include Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (11 papers) and Erythropoietin and Anemia Treatment (6 papers). Sukyung Woo is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (11 papers) and Erythropoietin and Anemia Treatment (6 papers). Sukyung Woo collaborates with scholars based in United States, Taiwan and Japan. Sukyung Woo's co-authors include William J. Jusko, Wojciech Krzyżański, William D. Figg, Raphaël Gottardo, Johanna Strobl, Sean M. Hughes, Claire Levy, Renan Sauteraud, Muneesh Tewari and Lamar Ballweber and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sukyung Woo

60 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions

2014 464 citations Sukyung Woo, Raphaël Gottardo et al. profile →

Peers

Countries citing papers authored by Sukyung Woo

Since Specialization

Citations

This map shows the geographic impact of Sukyung Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sukyung Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sukyung Woo more than expected).

Fields of papers citing papers by Sukyung Woo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sukyung Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sukyung Woo. The network helps show where Sukyung Woo may publish in the future.

Co-authorship network of co-authors of Sukyung Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Sukyung Woo. A scholar is included among the top collaborators of Sukyung Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sukyung Woo. Sukyung Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanistic intracellular PK/PD modeling to inform development strategies for small interfering RNA therapeutics 2025 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), Sukyung Woo	1
2	Comparison of red and green light for treating non‐muscle invasive bladder cancer in rats using singlet oxygen‐cleavable prodrugs with PPIX‐PDT 2024 ·Photochemistry and Photobiology ·(unknown), (unknown), Ganesh Bist, Sukyung Woo, Barbara A. Foster, Youngjae You	3
3	Enhancing PDT efficacy in NMIBC: Efflux inhibitor mediated improvement of PpIX levels and efficacy of the combination of PpIX‐PDT and SO‐cleavable prodrugs 2024 ·Photochemistry and Photobiology ·(unknown), (unknown), (unknown), Ganesh Bist, Barbara A. Foster, Sukyung Woo, Youngjae You	2
4	Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy 2024 ·Pharmaceutics ·(unknown), Miaomiao Li, Sukyung Woo	8
5	Mitochondrial targeting improves the selectivity of singlet‐oxygen cleavable prodrugs in NMIBC treatment 2024 ·Photochemistry and Photobiology ·(unknown), Ganesh Bist, (unknown), Barbara A. Foster, Sukyung Woo, Youngjae You	3
6	Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism 2021 ·Molecular Cancer Research ·Samrita Dogra, Deepika Neelakantan, (unknown), Beth Griesel, Ann Louise Olson, Sukyung Woo	38
7	Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN‐38, MMC and CA4: Nonmitochondria‐Targeted Prodrugs^† 2021 ·Photochemistry and Photobiology ·(unknown), Pritam Thapa, Robert E. Hurst, Sukyung Woo, Youngjae You	6
8	Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis 2019 ·Molecular Cancer Research ·Deepika Neelakantan, Samrita Dogra, (unknown), (unknown), (unknown), Ralf Janknecht, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, (unknown), Kai Ding, Sukyung Woo	27
9	Local and Systemic Antitumor Effects of Photo‐activatable Paclitaxel Prodrug on Rat Breast Tumor Models 2019 ·Photochemistry and Photobiology ·Subramaniyan Bharathiraja, Pallavi Rajaputra, (unknown), Mengjie Li, Cody J. Peer, (unknown), William D. Figg, Sukyung Woo, Youngjae You	3
10	Dosing for Fentanyl Infusion in Obese Children: Just Because It's What We Have Always Done Doesn't Mean It Is Right 2018 ·The Journal of Pediatric Pharmacology and Therapeutics ·(unknown), Sukyung Woo, Jamie L. Miller, (unknown), (unknown), Peter N. Johnson	2
11	Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells 2017 ·ACS Omega ·(unknown), Mengjie Li, Radha Karki, Moses Bio, Pallavi Rajaputra, Gregory Nkepang, Sukyung Woo, Youngjae You	38
12	Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology 2017 ·Journal of Controlled Release ·Jin Wang, Bertrand Z. Yeung, (unknown), Cody J. Peer, Ze Lu, William D. Figg, M. Guillaume Wientjes, Sukyung Woo, Jessie L.‐S. Au	72
13	Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity 2015 ·Leukemia ·Ann Dahlberg, Sukyung Woo, Colleen Delaney, Peter Boyle, Andreas Gnirke, Christoph Bock, B Bernstein, Alexander Meissner, Raphaël Gottardo, Irwin D. Bernstein	8
14	A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors 2012 ·Clinical Cancer Research ·Arun Rajan, Corey A. Carter, Ronan J. Kelly, Martin Gutierrez, Shivaani Kummar, Éva Szabó, Mary Ann Yancey, Jiuping Ji, Baskar Mannargudi, Sukyung Woo, Shawn D. Spencer, William D. Figg, Giuseppe Giaccone	125
15	Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia 2012 ·Clinical Cancer Research ·Cody J. Peer, Tristan M. Sissung, AeRang Kim, Lokesh Jain, Sukyung Woo, Erin R. Gardner, C. Tyler Kirkland, Sarah Troutman, Bevin C. English, Emily D. Richardson, Joel D. Federspiel, David Venzon, William L. Dahut, Elise C. Kohn, Shivaani Kummar, Robert Yarchoan, Giuseppe Giaccone, Brigitte C. Widemann, William D. Figg	108
16	Impact of ABCB1 Allelic Variants on QTc Interval Prolongation 2010 ·Clinical Cancer Research ·Tristan M. Sissung, Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo, Ryan M. Franke, James Clark, Laura Miller‐DeGraff, Seth M. Steinberg, David Venzon, David J. Liewehr, Steven R. Kleeberger, Susan E. Bates, Douglas K. Price, Douglas R. Rosing, Christopher H. Cabell, Alex Sparreboom, William D. Figg	24
17	Population Pharmacokinetics and Pharmacodynamics of Brief Etomidate Infusion in Healthy Volunteers 2010 ·The Journal of Clinical Pharmacology ·Kotaro Kaneda, Susumu Yamashita, Sukyung Woo, (unknown)	22
18	Methods of utilizing baseline values for indirect response models 2009 ·Journal of Pharmacokinetics and Pharmacodynamics ·Sukyung Woo, Dipti Pawaskar, William J. Jusko	24
19	Interspecies Comparisons of Pharmacokinetics and Pharmacodynamics of Recombinant Human Erythropoietin 2007 ·Drug Metabolism and Disposition ·Sukyung Woo, William J. Jusko	57
20	Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers 2007 ·The Journal of Clinical Pharmacology ·Sukyung Woo, Wojciech Krzyżański, Anne‐Marie Duliège, (unknown), (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Frapolli Breakdown of academic impact, for papers by Qing Xu Breakdown of academic impact, for papers by Dona Alberti Breakdown of academic impact, for papers by Cindy H. Chau Breakdown of academic impact, for papers by Xiangdong Cheng Breakdown of academic impact, for papers by Si Sun Breakdown of academic impact, for papers by Ting Gui Breakdown of academic impact, for papers by Philip M. Carpenter